The No-React process for biomaterials was suggested to prevent calcification and degeneration. We examined in vivo in a chronic sheep model the performance of a Biocor bovine internal mammary artery (BIMA) graft after No-React processing.
Methods:
‘No-React’ processing consists of aldehyde cross-linkage following a detoxification process with multiple physical variables and incubation with surfactant. Biocor BIMA No-React treated grafts have been interposed in the carotid artery in seven sheep with a Dacron graft as control. Grafts were explanted after 3 or 6 months and were grossly examined, by X-ray, histology, transmission and scanning electron microscopy, and atomic absorption spectrophotometry.
Results:
In the BIMA, good healing was found with a smooth intimal surface, minimal inflammatory reaction, and a well preserved ultrastructure. Calcification increased progressively. In the Dacron grafts, a fibrous covering the inner surface and infiltration with fibroblasts, histiocytes and macrophages was noted. Calcium content was stable.
Conclusion:
Calcification increased progressively in Biocor BIMA No-React grafts. Minimal inflammatory changes, a smooth inner surface and well preserved ultrastructure were noted.
DaleW.A.LewisM.R., Further experiences with bovine arterial grafts. Surgery, 1976, 80, 711–721.
2.
MonetaG. L.PorterJ. M., Arterial substitutes. In Textbook of Surgery, 14th edn, ed. SabistonD. C.Jr.W.B. Saunders Company, Philadelphia, 1991, pp. 1528–1539.
3.
YasharJ.J.RichmanM.H.DyckmanJ.WitoszkaM.BurnardR.J.WeymanA.K., Failure of Dacron prostheses caused by structural defect. Surgery, 1978, 84, 659–663.
4.
SottiuraiV.S.StanleyJ.C.FryW.J., Ultrastructure of human and transplanted canine veins: effect of different preparation media. Surgery, 1983, 93, 28–38.
5.
RosenbergN.ThompsonJ.E.KeshishianJ.M.Vander WerfB.A., The modified arterial bovine arterial graft. Archives of Surgery, 1976, 111, 222–226.
6.
RosenbergN., The bovine arterial graft and its several applications. Surgery in Gynecology and Obstetrics, 1976, 142, 104–108.
7.
WelchE.L.GearyJ.E., Femoro-popliteal by-pass with bovine heterografts. Journal of Cardiovascular Surgery Torino, 1976, 17, 62–68.
8.
AbolhodaA.YuS.OyarzunJ.R.McCormickJ.R.BogdenJ.GabbayS., Calcification of bovine pericardium: glutaraldehyde versus No-React biomodification. Annals of Thoracic Surgery, 1996, 62, 169–174.
9.
VrandecicM.O., New graft for the surgical treatment of small vessel diseases. Journal of Cardiovascular Surgery Torino, 1987, 28, 711–714.
10.
AbolhodaA.YuS.OyarzunJ.R.AllenK.R.McCormickJ.R.HanS., No-react detoxification process: a superior anticalcification method for bioprostheses. Annals of Thoracic Surgery, 1996, 62, 1724–1730.
11.
DardikH.MillerN.DardikA.IbrahimI.SussmanB.BerryS.M., A decade of experience with the glutaraldehyde-ranned human umbilical cord vein graft for revascularisation of the lower limb. Journal of Vascular Surgery, 1988, 7, 336–346.
12.
DardikH., The second decade of experience with the umbilical vein graft for lower-limb revascularisation. Cardiovascular Surgery, 1995, 3, 265–269.
13.
WilliamsG.M.Ter HaarA.KrajewskiC.ParksL.C.RothJ., Rejection and repair of endothelium in major vessel transplants. Surgery, 1975, 6, 694–706.
14.
KeshishianJ.M.SmythN.P.AdkinsP.C.CampF.YahrW.Z., Surgical techniques using the bovine arterial graft. Surgery in Gynecology and Obstetrics, 1971, 133, 268–272.
15.
CutlerB.S.ThompsonJ.E.PatmanR.D.PerssonA.V.ManfrediP.D., The modified bovine arterial graft: a clinical study. Surgery, 1974, 76, 963–973.
16.
KeshishianJ.M.SmithN.P.D.AdkinsP.C.CampF.YahrW.Z.HillL., Clinical experience with the modified bovine arterial heterograft. Journal of Cardiovascular Surgery Torino, 1971, 12, 433–140.
17.
SlovinJ.A., Arterial below the knee bypass grafts. Experience with the modified bovine heterograft. American Journal of Surgery, 1974, 128, 58–64.
18.
DaleW.A.LewisM.R., Modified bovine heterografts for arterial replacement. Annals of Surgery, 1969, 169, 927–946.
19.
VrandecicM.GontijoB. F.VrandecicE. A.FantiniF. A.VrandecicE., The first anticalcificant tanning of biological tissue with the full cytocompatibility initial comparative analysis. VIth International Symposium of Cardiac Bioprostheses, Vancouver, Canada, 1994, pp. 1–13.
20.
MaroisY.BoyerD.GuidoinR.DouvilleY.MaroisM.TeijeiraF.J., In vivo evaluation of four chemically processed biological grafts implanted as infrarenal arterial substitutes in dogs. Biomaterials, 1989, 10, 369–379.
21.
TeijeiraF.J.MaroisY.AguiarL.GuidoinR.BausetR.LamoureuxG., Comparision of processed bovine internal mammaries and autologous veins as arterial femoral substitutes in dogs: blood compatibility and pathological characteristics. Canadian Journal of Surgery, 1989, 32, 180–187.
22.
BruckS.D., Considerations of species-related hematological differences on the evaluation of biomaterials. Biomaterials, Medical Devices and Artificial Organs, 1977, 5, 97–113.
23.
HerijgersP.OzakiS.VerbekenE.Van LommelA.RàczR.ZietkiewiczM.PerekB.FlamengW., Calcification characteristics of porcine stentless valves in juvenile sheep. European Journal of Cardiothoracic Surgery, 1999, 15, 134–142.
24.
BarnhartG.R.JonesM.IshiharaT.RoseD.M.ChavezA.M.FerransV.J., Degeneration and calcification of bioprosthetic cardiac valves. Bioprosthetic tricuspid valve implantation in sheep. American Journal of Pathology, 1982, 106, 136–139.
25.
GabbayS.ChubackJ. A., In vitro and animal evaluation with Biocor No-React anticalcification treatment of bioprostheses (new concept in anticalcification treatment). In New Horizons and the Future of Heart Valve Bioprostheses, eds GabbayS.FraterR. W.Silent Partners, Inc, Austin, 1994, pp. 73–91.
26.
LundellA.BergqvistD.LindbladB.LeideS., The acute thrombogenicity of an infection-resistant rifampicin-soaked Dacron graft: an experimental study in sheep. European Journal of Vascular Surgery, 1992, 6, 403–407.
27.
TaylorA.AoP.FletcherJ., Inhibition of intimal hyperplasia and occlusion in Dacron graft with heparin and low molecular weight heparin. International Angiology, 1995, 14, 375–380.
